These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 31369873)

  • 1. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
    Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of novel intrinsic versus conventional antitachycardia pacing for ventricular tachycardia among implantable cardioverter-defibrillator recipients.
    Yanagisawa S; Inden Y; Sato Y; Watanabe R; Goto T; Kondo S; Tachi M; Iwawaki T; Yamauchi R; Hiramatsu K; Shimojo M; Tsuji Y; Shibata R; Murohara T
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):821-831. PubMed ID: 38424678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal programming management of ventricular tachycardia storm in ICD patients.
    Qian Z; Guo J; Zhang Z; Wang Y; Hou X; Zou J
    J Biomed Res; 2015 Jan; 29(1):35-43. PubMed ID: 25745473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes.
    Fang Y; Gu K; Yang B; Ju W; Chen H; Li M; Liu H; Wang J; Yang G; Chen M
    J Arrhythm; 2018 Feb; 34(1):36-45. PubMed ID: 29721112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in-silico assessment of efficacy of two novel intra-cardiac electrode configurations versus traditional anti-tachycardia pacing therapy for terminating sustained ventricular tachycardia.
    Qian S; Connolly A; Mendonca-Costa C; Campos F; Williams SE; Whitaker J; Rinaldi CA; Bishop MJ
    Comput Biol Med; 2021 Dec; 139():104987. PubMed ID: 34741904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279].
    Wilkoff BL; Stern R; Williamson B; Wathen M; Holloman K; Fieberg A; Brown M
    Trials; 2006 May; 7():18. PubMed ID: 16725036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year outcomes after stereotactic body radiotherapy for refractory ventricular tachycardia.
    Arkles J; Markman T; Trevillian R; Yegya-Raman N; Garg L; Nazarian S; Santangeli P; Garcia F; Callans D; Frankel DS; Supple G; Lin D; Riley M; Kumaraeswaran R; Marchlinski F; Schaller R; Desjardins B; Chen H; Apinorasethkul O; Alonso-Basanta M; Diffenderfer E; Kim MM; Feigenberg S; Zou W; Marcel J; Cengel KA
    Heart Rhythm; 2024 Jan; 21(1):18-24. PubMed ID: 37827346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-derived cycle length variability metrics predict spontaneously terminating ventricular tachycardia in implantable cardioverter defibrillator recipients.
    Sau A; Ahmed A; Chen JY; Pastika L; Wright I; Li X; Handa B; Qureshi N; Koa-Wing M; Keene D; Malcolme-Lawes L; Varnava A; Linton NWF; Lim PB; Lefroy D; Kanagaratnam P; Peters NS; Whinnett Z; Ng FS
    Eur Heart J Digit Health; 2024 Jan; 5(1):50-59. PubMed ID: 38264702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry.
    Beyer SE; Harrell C; Mullane S; Kutyifa V; Madhavan M; Piccini JP; Upadhyay GA; Ip JE; Thomas G; Liu CF; Markowitz SM; Hayes D; Lerman BB; Cheung JW
    J Am Heart Assoc; 2024 Jul; ():e034500. PubMed ID: 39011955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study.
    Chinushi M; Saitoh O; Furushima H; Aizawa Y; Noda T; Nitta T; Ohe T; Kurita T
    J Arrhythm; 2021 Aug; 37(4):1038-1045. PubMed ID: 34386130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate implantable cardioverter defibrillator shocks due to atrial far-field on the tip-to-ring channel for lead dislodgement.
    Ferretto S; Brunzin K; Pettenuzzo K; Nangah Suh R; Canali C; Di Pede F
    J Arrhythm; 2019 Jun; 35(3):562-564. PubMed ID: 31293710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular arrhythmias among patients with implantable cardioverter-defibrillator during the COVID-19 pandemic.
    Malanchini G; Ferrari P; Leidi C; Ferrari G; Racheli M; Senni M; De Filippo P
    J Arrhythm; 2021 Apr; 37(2):407-413. PubMed ID: 33821178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to defibrillate or cardiovert due to premature truncation of biphasic shocks from implantable defibrillators.
    Hauser RG; Kapphahn-Bergs M; Casey SA; Witt DR; Sengupta JD
    Heart Rhythm; 2024 Feb; 21(2):143-149. PubMed ID: 37956776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable Cardioverter-Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto.
    Savona S; Weiss R
    J Am Heart Assoc; 2024 Jul; ():e036211. PubMed ID: 39011962
    [No Abstract]   [Full Text] [Related]  

  • 15. Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming.
    Pavlenko T; Cunha PS; Oliveira MM
    Rev Port Cardiol; 2024 Jul; ():. PubMed ID: 38964465
    [No Abstract]   [Full Text] [Related]  

  • 16. One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention?
    Cakulev I; Mackall JA
    Heart Rhythm O2; 2020 Jun; 1(2):83-84. PubMed ID: 34115051
    [No Abstract]   [Full Text] [Related]  

  • 17. RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy.
    Tsukahara K; Oginosawa Y; Fujino Y; Honda T; Kikuchi K; Nozoe M; Uchida T; Minamiguchi H; Sonoda K; Ogawa M; Ideguchi T; Kizaki Y; Nakamura T; Oba K; Higa S; Yoshida K; Yagyu K; Miyamoto T; Yamagishi Y; Ohe H; Kohno R; Kataoka M; Otsuji Y; Abe H
    J Arrhythm; 2021 Aug; 37(4):1052-1060. PubMed ID: 34386132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
    Joung B; Lexcen DR; Ching CK; Silver MT; Piccini JP; Sterns LD; Rabinovich R; Pickett RA; Liu S; Brown ML; Cheng A
    Heart Rhythm; 2020 Jan; 17(1):98-105. PubMed ID: 31369873
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.